Conformis Inc (45)

Browse by Contract Category

Contracts

Form of Performance-Based Restricted Stock Unit Agreement under 2015 Stock Incentive Plan (Filed With SEC on August 4, 2021)
Fifth Amendment dated March 1, 2021 to Loan and Security Agreement by and between Conformis, Inc., ImaTx, Inc., Conformis Cares LLC and Innovatus Life Sciences Lending Fund I, LP (Filed With SEC on March 4, 2021)
Placement Agent Agreement, dated as of September 23, 2020, by and between Conformis and Oppenheimer & Co. Inc (Filed With SEC on September 24, 2020)
Sales Agreement, dated August 5, 2020, by and between Conformis, Inc. and Cowen and Company, LLC (Filed With SEC on August 5, 2020)
License Agreement, dated as of September 30, 2019, by and between Howmedica Osteonics Corp. and Conformis, Inc (Filed With SEC on November 1, 2019)
Conformis, Inc. 2015 Stock Incentive Plan, as Amended by Amendment No. 1 thereto (Filed With SEC on May 27, 2021)
Underwriting Agreement, dated as of February 12, 2021, by and between Conformis and Oppenheimer & Co. Inc (Filed With SEC on February 17, 2021)
Form of Global Nonstatutory Stock Option Agreement under 2015 Stock Incentive Plan (Filed With SEC on November 4, 2020)
Fourth Amendment, dated August 20, 2020, to Loan and Security Agreement by and between Conformis, Inc., ImaTx, Inc., Conformis Cares LLC and Innovatus Life Sciences Lending Fund... (Filed With SEC on November 4, 2020)
Form of Pre-Funded Warrant (Filed With SEC on September 24, 2020)
Form of Common Stock Warrant (Filed With SEC on September 24, 2020)
Form of Subscription Agreement (Filed With SEC on September 24, 2020)
Form of Global Restricted Stock Agreement under 2015 Stock Incentive Plan (Filed With SEC on August 5, 2020)
Third Amendment to Loan and Security Agreement by and between Conformis, Inc., ImaTx, Inc., Conformis Cares LLC and Innovatus Life Sciences Lending Fund I, LP (Filed With SEC on July 6, 2020)
Settlement and License Agreement, dated May 22, 2020, by and between Zimmer Biomet Holdings, Inc., Zimmer, Inc., Zimmer US, Inc. and Biomet Manufacturing, LLC, and Conformis, Inc (Filed With SEC on May 28, 2020)
Consent Under Loan and Security Agreement, dated as of April 17, 2020, by and among Conformis, Inc. and the other parties thereto (Filed With SEC on May 11, 2020)
Second Amendment to Loan and Security Agreement, dated as of March 1, 2020, by and among Conformis, Inc. and the other parties thereto (Filed With SEC on May 11, 2020)
Promissory Note, dated as of April 9, 2020 (Filed With SEC on April 20, 2020)
Form of Inducement Incentive Grant Agreement (Filed With SEC on March 3, 2020)
Consulting Agreement, effective as of February 17, 2020, by and between Conformis, Inc. and Frederick W. Driscoll, its former Interim Chief Financial Officer (Filed With SEC on March 3, 2020)
Employment Agreement, effective as of February 17, 2020, by and between Conformis, Inc. and Robert Howe, its Chief Financial Officer (Filed With SEC on March 3, 2020)
Fifth Amendment to Amended and Restated Employment Agreement dated February 4, 2020, by and between Conformis, Inc. and Mark Augusti, its Chief Executive Officer (Filed With SEC on March 3, 2020)
Form of Inducement Restricted Stock Unit Agreement (Filed With SEC on March 3, 2020)
First Amendment to Employment Agreement dated December 23, 2019, by and between Conformis, Inc. and J. Brent Alldredge, its Chief Legal Officer and Corporate Secretary (Filed With SEC on March 3, 2020)
Extension dated December 19, 2019 to Offer Letter dated October 14, 2019, by and between Conformis, Inc. and Frederick W. Driscoll, its Interim Chief Financial Officer (Filed With SEC on March 3, 2020)
Fourth Amendment to Amended and Restated Employment Agreement dated November 2, 2019, by and between Conformis, Inc. and Mark Augusti, its Chief Executive Officer (Filed With SEC on March 3, 2020)
Offer Letter dated October 14, 2019, by and between Conformis, Inc. and Frederick W.Driscoll, its Interim Chief Financial Officer (incorporated herein by reference to the... (Filed With SEC on March 3, 2020)
Description of securities (Filed With SEC on March 3, 2020)
Form of 2015 Stock Incentive Plan Restricted Stock Grant for Independent Sales Representative (Filed With SEC on March 3, 2020)
Form of 2020 Incentive Compensation Program Award Letter (Filed With SEC on February 5, 2020)
First Amendment to Asset Purchase Agreement, dated as of October 23, 2019, by and between Howmedica Osteonics Corp. and Conformis, Inc (Filed With SEC on November 1, 2019)
First Amendment to Loan and Security Agreement, dated as of August 15, 2019, by and among Conformis, Inc. and the other parties thereto (Filed With SEC on November 1, 2019)
Asset Purchase Agreement, dated as of September 30, 2019, by and between Howmedica Osteonics Corp. and Conformis, Inc (Filed With SEC on November 1, 2019)
Distribution Agreement, dated as of September 30, 2019, by and between Howmedica Osteonics Corp. and Conformis, Inc (Filed With SEC on November 1, 2019)
Form of 2015 Stock Incentive Plan Performance-Vested Restricted Stock Agreement (Filed With SEC on November 1, 2019)
Development Agreement, dated as of September 30, 2019, by and between Howmedica Osteonics Corp. and Conformis, Inc (Filed With SEC on November 1, 2019)
Form of 2019 Sales Team Performance-Based Equity Incentive Plan Performance-Vested Restricted Stock Agreement (Filed With SEC on November 1, 2019)
Consulting Agreement, effective as of October 19, 2019, by and between Conformis, Inc. and Paul S. Weiner (Filed With SEC on October 4, 2019)
Employment Agreement dated July 29, 2019, by and between Conformis, Inc. and J. Brent Alldredge, its Chief Legal Officer and Corporate Secretary (Filed With SEC on August 2, 2019)
Loan and Security Agreement, dated as of June 25, 2019, by and among Conformis, Inc. and the other parties thereto (Filed With SEC on June 26, 2019)
Registration Rights Agreement, dated as of June 25, 2019, by and among Conformis, Inc., Innovatus Life Sciences Lending Fund I, LP, Innovatus Life Sciences Offshore Fund I, LP and... (Filed With SEC on June 26, 2019)
Investment Agreement, dated as of June 25, 2019, by and among Conformis, Inc., Innovatus Life Sciences Lending Fund I, LP, Innovatus Life Sciences Offshore Fund I, LP and... (Filed With SEC on June 26, 2019)
Form of 2018 Incentive Compensation Program Award Letter (Filed With SEC on March 14, 2019)
Form of 2019 Incentive Compensation Program Award Letter (Filed With SEC on March 14, 2019)
Amendment to Employment Agreement dated March 8, 2019, by and between Conformis, Inc. and March Augusti, its President and Chief Executive Officer (Filed With SEC on March 13, 2019)